Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SRTS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSensus Healthcare stockholders re-elect directors, approve executive pay in routine annual meeting
Filed June 2, 2026 · Period ending May 29, 2026 · ~1 min read
Key Changes
-
low
Stockholders re-elected Eric Sachetta and Michael Sardano as Class II directors for three-year terms expiring in 2029, with Sachetta receiving 91% support and Sardano 78% of votes cast.
Item 5.07 verify on EDGAR → -
low
Executive compensation for 2025 received non-binding stockholder approval with 82% support, indicating general acceptance of management pay practices.
Item 5.07 verify on EDGAR → -
low
Carr, Riggs & Ingram retained as independent auditor for 2026 with 99% stockholder approval, maintaining continuity in external audit relationship.
Item 5.07 verify on EDGAR →
Summary
Sensus Healthcare held its annual stockholder meeting on May 29, 2026, completing standard corporate governance matters with no surprises. The company successfully re-elected both incumbent Class II directors to three-year terms, though Michael Sardano's lower approval rate (78% versus Sachetta's 91%) may warrant monitoring in future votes. The say-on-pay vote passed comfortably at 82%, suggesting stockholders are generally satisfied with executive compensation practices.
For retail investors, this filing represents routine corporate housekeeping with no material business developments. The strong auditor ratification (99% approval) and successful director elections indicate stable governance. Watch for the company's next quarterly earnings report or business updates for meaningful operational information, as annual meeting results typically don't move the needle on valuation or strategy.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Sensus Healthcare held its annual stockholder meeting on May 29, 2026, electing two Class II directors and ratifying auditor appointment.
Show 3 minor / wording changes
Added in current filing · verify on EDGAR →
Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term to expire in 2029.
Stockholders re-elected two incumbent Class II directors to serve three-year terms expiring in 2029. Eric Sachetta received 5,532,247 votes for and 516,567 against; Michael J. Sardano received 4,702,852 votes for and 1,346,063 against. Both elections were successful despite broker non-votes exceeding 5 million shares.
Added in current filing · verify on EDGAR →
Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for 2025.
Stockholders approved executive compensation for 2025 on a non-binding advisory basis with 4,740,572 votes for, 856,128 against, and 722,554 abstentions. This say-on-pay vote indicates general stockholder support for management compensation practices, though it is advisory only and does not bind the board.
Added in current filing · verify on EDGAR →
Stockholders ratified the appointment of Carr, Riggs & Ingram, LLC as the Company’s independent registered public accountant for the fiscal year ended December 31, 2026.
Stockholders ratified Carr, Riggs & Ingram, LLC as the independent auditor for fiscal year 2026 with overwhelming support: 10,738,792 votes for versus 148,466 against. This routine ratification confirms continuity in the company's external audit relationship.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify